Auditory neuropathy spectrum disorder (ANSD) has an effect, either directly or indirectly, on the neural processing of auditory stimuli. Physiological measures are needed to accurately identify and assess ANSD. Sound processing in patients with ANSD is highly variable, and relationships between hearing sensitivity and ability to process speech do not follow the typical hearing loss rules. Auditory function may show changes over time, with progression or fluctuation, or may remain stable. Considerable variation in presentation is observed across patients of all ages and includes milder forms of ANSD. Based on these observations, management should proceed with thorough assessment of individual capabilities. It is important to distinguish between detection (sensitivity) and discrimination of sound, especially in noise, when evaluating function and benefit from various forms of management. Visual information is important for most patients and cochlear implants provide significant benefit when that option is selected. As the understanding of ANSD and the inherent variation among patients advances, the knowledge and methods that we bring to our clinical practices should allow us to more accurately characterize function and implement appropriate management.
Patients with present cochlear responses and absent/abnormal auditory brain stem responses (ABRs) are classified as having auditory neuropathy (AN), 1 AN/dys-synchrony (AD), 2 or AN spectrum disorder (ANSD). 3 Though these terms have somewhat different intended meanings and origins, at present they often are used interchangeably. More specific and accurate descriptors will likely emerge with better understanding of underlying mechanisms. Clinical presentation in AN (AN/AD, ANSD) typically involves inordinate difficulty listening in noise, possible fluctuation in hearing over time, and/or delayed speech and language development. Some patients with fluctuations in auditory responses accompanying elevated temperature are reported. 4 Physiological responses are key factors in accurately identifying and characterizing AN. Presence of cochlear responses is documented by otoacoustic emissions (OAE) and cochlear microphonics. Neural responses are either directly or indirectly affected, and abnormalities are demonstrated by absent or highly abnormal ABRs, middle ear muscle reflexes (MEMRs), and medial olivocochlear reflexes (noted via OAE suppression). Behavioral responses are variable as shown by audiometric configurations from normal to profound ranges and variable but generally poor speech recognition, particularly in noise.
VARIATION AMONG PATIENTS WITH ANSD
Variation is broad among ANSD patients. 5, 6 Factors related to variation include time of onset, underlying mechanisms, genetics, possible risk factors, ability to understand speech, and changes over time. Some patients display no overt delays or auditory complaints until adulthood or in some cases until, by chance, MEMR or ABR testing is completed. Patients at the other end of the continuum display an apparent total lack of sound awareness, reflected in their severely affected communication and speech production abilities. However, most ANSD patients fall between these two extremes, showing inconsistent auditory responses with best responses in quiet and poorest in noise. Their audiograms can be misleading or fluctuate. The ABR is desynchronized and middle-ear muscle reflexes are absent or in some cases elevated.
These characteristics, and particularly their variation, present the clinician with several challenges. Accurate characterization of ANSD includes understanding variation among and within particular forms of ANSD along with the ability to identify factors contributing to the variation. As our understanding of the underlying mechanisms, physiological responses, and genetic factors improves, so should our ability to better characterize and distinguish among forms of ANSD. More accurate characterization should also have a positive impact on management planning.
To understand the characteristics and variation of ANSD, we (the group at the Kresge Hearing Research Laboratory) developed a database of patients and recently summarized data related to 260 of those patients. 6 Most of these patients are under 12 years of age, though some adults also are included. The majority of the patients are pediatric because these are the groups who are actively being tested through newborn hearing and school screening programs. We believe that there are adults with ANSD who simply have not been identified.
Patients were included in the database based on presence of OAEs (currently or at some point in their history) and cochlear microphonics with absent or abnormal MEMRs and ABRs. Review of OAE data showed that 76% of the patients had present OAEs when the diagnostically definitive testing for AN/AD was completed. About 16% had absent OAEs, which in most cases was accompanied by abnormal middle-ear test results, and the remaining patients had partially present OAEs. MEMRs were absent in 90% of patients.
patients had absent ABRs, and 25% showed some evidence of neural responses. In these cases, ABRs typically showed only low-amplitude wave V and, as noted earlier, only at higher (i.e., 75 dB hearing level in normal listeners for brief signals and above) intensities.
The variation among individuals in behavioral responses highlights the importance of physiological responses in assessment and makes management of ANSD particularly challenging. Thresholds for tonal stimuli (e.g., pure-tone audiometric thresholds) range from normal to profound. Speech recognition is typically poorer than seen in other forms of hearing loss, though some patients display quite good word recognition in quiet. All ANSD patients tested thus far in our experience have very poor (i.e., poorer than expected based on threshold sensitivity) speech understanding ability in noise.
As a part of our database analysis, we summarized speech recognition ability for 68 subjects over the age of 4 years. 6 Our rationale for limiting the analysis to this age range related to the ability to use standardized assessment measures. In this group, 38 of the 68 individuals had no word recognition ability for monosyllables in quiet. Thus, the remainder of the analysis focused on the remaining 30 subjects. Of those, 25 had measureable word recognition only in quiet (i.e., 0% in noise). Word recognition in quiet averaged 45% in this group, with some patients having very poor word recognition ability (i.e., < 20%) and others quite good (i.e., > 80%). The five subjects of the original 30 with word recognition ability in quiet and in noise are our best performers and, despite quite good ability in quiet, they still fall below those with other forms of hearing loss in noise. These findings are quite consistent with those reported by Rance et al. 9 Difficulty in understanding speech has been linked to marked abnormalities observed on temporal processing tasks. 10, 11 The incidence of ANSD is 1 in 10 patients with desynchronized ABRs. This is based on several studies that have included data from newborn screening as well as evaluation of children enrolled in schools for the deaf. [12] [13] [14] [15] Several factors have been explored in relation to ANSD. In our database, 6.2% display unilateral ANSD, with the majority having normal hearing in the other ear. Some risk factors are often seen in the history of individuals with ANSD, and we and others have summarized those. 6, 16, 17 Several genetic mutations have been identified that are associated with ANSD. 18, 19 Families display recessive and dominant inheritance patterns, as well as some that are likely mitochondrial in nature. ANSD occurs alone, as in nonsyndromic recessive ANSD, as well as part of a syndrome, such as hereditary motor sensory neuropathies. Among the various genes linked to ANSD, OTOF mutations, responsible for production of the protein otoferlin, with localized expression at the inner hair cell synaptic juncture, have been of particular interest.
IMPLICATIONS OF VARIABLE FUNCTION FOR MANAGEMENT OF PATIENTS WITH ANSD
Management of ANSD differs from typical sensorineural hearing loss. In many cases, discrimination of sound is affected to a much greater degree than detection of sound. For example, some patients have quite good sound detection with threshold sensitivity in the mild hearing loss range but have very poor or no word and sentence understanding.
Variation in clinical presentation is further highlighted by differences among patients in the effectiveness of various management approaches. Although some patients are reported to demonstrate benefit from amplification, the majority of patients with ANSD in our practices (Louisiana State University Health Sciences Center-New Orleans and Vanderbilt University) have not been successful in using amplification alone to facilitate the development of speech and language or general communication. We evaluate the effectiveness of amplification in all of our ANSD patients who demonstrate reduced threshold sensitivity to sound. In our practice, we fit amplification using targets based on behavioral thresholds, which typically can be obtained at an age of around 6 months. A key factor in assessing benefit is separating improvement from detection of sound, where we typically observe changes postfitting, from ability related to discrimination of sound. Because discrimination of sound is necessary for communication and speech and language development, we closely follow each individual's progress in assessing the effectiveness of amplification.
Assistive listening (FM) devices are very helpful, which is consistent with the particular difficulty that ANSD patients experience in noisy situations. The improved signal-to-noise ratios provide a clearer signal to an auditory system that cannot cope with interference. 20 In addition, use of visual information is strongly encouraged in the management of ANSD patients. Communication systems, such as cued speech or sign languages, facilitate language development in infants and children. 21 Both children and adults with ANSD demonstrate improved speech perception and significant benefit from cochlear implants. [22] [23] [24] [25] Despite variation among patients and early reports of limited benefit, ANSD patients generally derive considerable benefit from cochlear implants in improved hearing and speech perception abilities. As might be expected, more favorable postimplantation speech perception scores are reported for ANSD subjects with normal cochlear nerves as compared with those with cochlear nerve anomalies. 26, 27 Other techniques such as clear speech 25 and envelope enhancement 28 show some promise in improving word recognition.
FUTURE NEEDS: ISSUES AND CHALLENGES
Although our understanding of ANSD has advanced, several issues and challenges remain. The observed variation among patients highlights the importance of developing information and methods that will allow clinicians to accurately distinguish among the various forms of ANSD. Progress in this area will likely include the development of methods that can accurately distinguish normal from abnormal function at inner hair cell, synaptic juncture, and neural levels and the identification of specific risk factors related to ANSD. Even within various forms of ANSD, we expect that variation will exist, and we need to understand the range of variation, the role of genetics and variation within and among genetic mutations, and other contributing physiological and environmental factors.
Another challenge in evaluating and managing ANSD in infants is distinguishing between neuromaturation of the auditory system, where neural responses improve over the first year or so of life, and true ANSD. Are there characteristics of physiological responses, patient history, or other factors that can distinguish neuromaturation from ANSD? In infants and children with ANSD, how can we predict who will develop speech/language with minimal intervention despite poor neural synchrony reflected in absent or highly abnormal ABRs? In developing appropriate management strategies and an evidence base, guidelines are needed for determination of appropriate recommendations and fitting practices for hearing aids, frequency modulation systems, cochlear implants, and appropriate use of various intervention strategies.
Studies of patients with ANSD have demonstrated sensitivity of electrocochleography and compound action potential physiological responses from the cochlea and VIIIth nerve in characterizing variation in function among patients. 29, 30 Psychophysical tasks, particularly those related to temporal resolution, and cortical responses provide insight into underlying mechanisms and functional abilities. Cortical evoked potentials also show promise in characterizing auditory function objectively and in establishing links with speech recognition. 31, 32 As future clinical assessment facilitates greater use of novel stimuli and paradigms, more sensitive approaches, and development of clinically feasible methods that include these advances, we should be able to more accurately characterize and understand the variation we observe in ANSD. This understanding also should support more informed approaches to patient management.
